Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug war coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    Florida Prisoner Bill of Rights Faces House Subcommittee Hurdle, Again

    Legislators are weighing a proposal to establish a bill of rights for people in ...

    author_avatar
    Kastalia Medrano

    House Resumes Push to Call Fentanyl a Weapon of Mass Destruction

    In Ohio, legislation that urges the Secretary of Homeland Security to designate non-pharmaceutical fentanyl ...

    author_avatar
    Kastalia Medrano

    FCC Reveals Plan to Nearly Double Price Caps for Prison, Jail Phone Calls

    After weeks of hinting at a forthcoming proposal that could upend the ongoing battle ...

    author_avatar
    Kastalia Medrano

    DEA Raises Adderall Production Quotas for the First Time

    The Drug Enforcement Administration has raised aggregate production quotas (APQ) for the active ingredients ...

    author_avatar
    Kastalia Medrano

    FCC Proposes Revised, Higher Price Caps for Prison and Jail Phone Calls

    The Federal Communications Commission (FCC) has proposed a revision of its historic regulations lowering ...

    author_avatar
    Kastalia Medrano

    New “Fentanyl Poisonings” Act Would Target Social Media Sales, Again

    In late September, Representatives Adam Gray (D-CA) and Gabe Evans (R-CO) introduced the “Combatting ...

    author_avatar
    Kastalia Medrano

    Opvee, High-Profile Overdose Antidote No One Used, Discontinues Marketing

    Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical ...

    author_avatar
    Kastalia Medrano

    WI May Expand “Good Samaritan” Law to 911 Calls for Sexual Assault

    Wisconsin is considering a proposal to offer legal immunity from certain controlled substance charges ...

    author_avatar
    Kastalia Medrano

    Landmark Deals Drop New Injectable PrEP From $28,000 to $40—for Some

    Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with ...

    author_avatar
    Kastalia Medrano

    SAMHSA Awards Opioid Response Grants Amid New “Strategic Priorities”

    On September 22, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the ...

    author_avatar
    Kastalia Medrano